TABLE OF CONTENTS
TTA commits to the purposes of the World Anti-Doping Program and the Code, namely:
· to protect the Athletes’ fundamental right to participate in Doping free sport and thus promote health, fairness and equality for Athletes worldwide; and
· to ensure harmonised, coordinated and effective anti-doping programs at the international and national level with regard to detection, deterrence and prevention of Doping.
The fundamental rational of this Policy is the preservation of the spirit of sport, namely the celebration of the human spirit, body and mind, and is characterised by the following values:
· Ethics, fair play and honesty;
· Excellence in performance;
· Character and education;
· Fun and joy;
· Dedication and commitment;
· Respect for rules and laws;
· Respect for self and other participants;
· Community and solidarity.
Doping is fundamentally contrary to the spirit of sport.
This policy applies to:
c. Athlete Support Personnel;
Employees and contractors of TTA.
3.1 The policies and minimum standards set forth in the Code and implemented in this Anti-Doping Policy represent the consensus of a broad spectrum of stakeholders with an interest in fair sport. The persons identified in Article 2 are bound by this Anti-Doping Policy as a condition of their participation and/or involvement in the sport.
3.2 Roles and responsibilities – Athletes:
3.2.1 must be knowledgeable of and comply with all anti-doping policies and rules applicable to them;
3.2.2 must read and understand the Prohibited List as it relates to them;
3.2.3 must be available for Sample collection and provide appropriate whereabouts information for this purpose when included in a Registered Testing Pool;
3.2.4 must take full responsibility, in the context of anti-doping, for what they ingest and Use;
their obligations not to Use Prohibited Substances and Prohibited
Methods and to take responsibility to make sure that any medical treatment
received does not violate anti-doping policies and rules applicable to them;
3.2.6 who are not regular Members of TTA must be available for Sample collection and provide accurate and up-to-date whereabouts information on a regular basis if required by the conditions of eligibility established by TTA, the AOC, the APC, the ITTF, the ACGA or as applicable.
3.3 Roles and responsibilities – Athlete Support Personnel must:
3.3.1 be knowledgeable of and comply with all anti-doping policies and rules applicable to them or the Athletes whom they support;
3.3.2 support and assist Anti-Doping Organisations, including ASDA to conduct Doping Control; and
3.3.3 use their influence on Athletes values and behaviour to foster anti-doping attitudes.
3.5 Roles and responsibilities – TTA should:
3.5.1 use its best efforts to assist Athletes to fulfil their responsibilities under this Anti-Doping Policy, including providing accurate Athlete contact information;
3.5.2 support and assist Anti-Doping Organisations, including ASDA to conduct Doping Control;
3.5.3 make reasonable efforts to make this Policy available to Members, Athletes and Athlete Support Personnel and Persons;
3.5.4 develop and implement, in consultation with ASDA and the ITTF, drug education and information programs for Athletes and Athlete Support Personnel;
3.5.5 support the initiatives of the ASC, ASDA, the ITTF, the AOC, the APC and the ACGA to stop Doping in sport;
3.5.6 adopt and implement Anti-Doping policies and rules which conform with the Code, the ITTF Anti Doping Rules, the AOC Anti Doping Policy and the ASC Anti-Doping Core Provisions;
3.5.7 cooperate with the ASC and other Anti-Doping Organisations in relation to the conduct of any investigation or hearing into an alleged Anti-Doping Rule Violation.
require as a condition
of membership that the policies, rules and programs of Member organisations
are in compliance with the Code the ITTF, the AOC
and this Anti-Doping Policy;
require all Athletes
and Athlete Support Personnel within their jurisdiction to recognise
and be bound by anti-doping rules in conformance with the Code
the ITTF, the AOC
the ASC and
this Anti-Doping Policy;
3.5.10 require Athlete(s) who are not regular Members of TTA or one of its Member organisations to be available for Sample collection and provide accurate and up-to-date whereabouts information if required by the conditions for eligibility established by TTA, the AOC, the APC, the ITTF, the ACGA; and
3.5.11 not disclose or use any information about a person who is alleged to have, or has committed an Anti-Doping Rule Violation until after the conclusion of the hearing, except (for a purpose under these rules) to the ASC, ASDA and relevant Anti-Doping Organisations.
Doping is defined as the occurrence of one or more of the Anti-Doping Rule Violations set forth in Article 5.1 through Article 5.8 of this Anti-Doping Policy.
The following constitute Anti-Doping Rule Violations:
5.1 The presence of a Prohibited Substance or its Metabolites or Markers in an Athlete's bodily Specimen.
5.1.1 It is each Athlete's personal duty to ensure that no Prohibited Substance enters his or her body. Athletes are responsible for any Prohibited Substance or its Metabolites or Markers found to be present in their bodily Specimens. Accordingly, it is not necessary that intent, fault, negligence or knowing Use on the Athlete's part be demonstrated in order to establish an anti-doping violation under Article 5.1.
5.1.2 Excepting those substances for which a quantitative reporting threshold is specifically identified in the Prohibited List, the detected presence of any quantity of a Prohibited Substance or its Metabolites or Markers in an Athlete’s Sample shall constitute an Anti-Doping Rule Violation.
5.1.3 As an exception to the general rule of Article 5.1, the Prohibited List may establish special criteria for the evaluation of Prohibited Substances that can also be produced endogenously.
5.2 Use or Attempted Use of a Prohibited Substance or a Prohibited Method.
5.2.1 The success or failure of the Use of a Prohibited Substance or Prohibited Method is not material. It is sufficient that the Prohibited Substance or Prohibited Method was Used or Attempted to be Used for an Anti-Doping Rule Violation to be committed.
5.3 Refusing, or failing without compelling justification, to submit to Sample collection after notification as authorised in this Anti-Doping Policy, or otherwise evading Sample collection.
5.4 Violation of the requirements regarding Athlete availability for Out-of Competition Testing including failure to provide required whereabouts information set forth in Article 8.3 (Athlete whereabouts requirements) and missed tests which are declared based on reasonable rules.
5.5 Tampering, or Attempting to tamper, with any part of Doping Control.
5.6 Possession of Prohibited Substances and Methods.
5.6.1 Possession by an Athlete at any time or place of a substance that is prohibited in Out-of-Competition Testing or a Prohibited Method unless the Athlete establishes that the Possession is pursuant to a Therapeutic Use Exemption granted in accordance with Article 7.4 (Therapeutic Use) or other acceptable justification.
5.6.2 Possession of a Prohibited Substance that is prohibited in Out-of-Competition Testing or a Prohibited Method by Athlete Support Personnel in connection with an Athlete, Event or training, unless the Athlete Support Personnel establishes that the Possession is pursuant to a Therapeutic Use Exemption granted to an Athlete in accordance with Article 7.4 (Therapeutic Use) or other acceptable justification.
5.7 Trafficking in any Prohibited Substance or Prohibited Method.
5.8 Administration or Attempted administration of a Prohibited Substance or Prohibited Method to any Athlete, or assisting, encouraging, aiding, abetting, covering up or any other type of complicity involving an Anti-Doping Rule Violation or any Attempted violation.
6.1 Burdens and Standards of Proof.
or shall have the burden of establishing that
an Anti-Doping Rule Violation has occurred. The standard of proof shall be
has established an Anti-Doping Rule Violation to the comfortable
satisfaction of the hearing body bearing in mind the seriousness of the allegation
which is made. This standard of proof in all cases is greater than a mere
balance of probability but less than
proof beyond a reasonable doubt. Where this policy places the burden of proof upon the Athlete
or other Person alleged
to have committed an
Anti-Doping Rule Violation to rebut a presumption or establish specified facts or circumstances, the standard of proof shall be by a balance of probability.
6.2 Methods of Establishing Facts and Presumptions.
Facts related to Anti-Doping Rule Violations may be established by any reliable means, including admissions. The following rules of proof shall be applicable in Doping cases:
6.2.1 WADA-accredited laboratories are presumed to have conducted Sample analysis and custodial procedures in accordance with the International Standard for Laboratory Analysis. The Athlete may rebut this presumption by establishing that a departure from the International Standard occurred.
If the Athlete rebuts the preceding
presumption by showing that a departure from the International Standard occurred, then
shall have the burden to establish that such departure did not cause the
Adverse Analytical Finding.
6.2.2 Departures from the International Standard for Testing
which did not cause an Adverse
Analytical Finding or other Anti-Doping Rule Violation shall
not invalidate such results. If the Athlete establishes that departures from the International Standard occurred during Testing then the TTA
or shall have the burden
to establish that such departures did not cause the Adverse
Analytical Finding or the factual basis for the Anti-Doping Rule
7.1 Incorporation of the Prohibited List.
This Anti-Doping Policy incorporates the Prohibited List which is published and revised by WADA as described in Article 4.1 of the Code and is available on WADA's website at www. wada-ama.org and changes from time to time.
7.2 Prohibited Substances and Prohibited Methods Identified on the Prohibited List.
Unless provided otherwise in the Prohibited List and/or a revision, the Prohibited List and revisions shall go into effect under this Anti-Doping Policy three months after publication of the Prohibited List by WADA without requiring any further action by TTA. In accordance with Article 4.2 of the Code the Prohibited List is the expanded List adopted by the ITTF and the Monitoring Program is the Program including additional substances and methods adopted by the ITTF.
7.3 Criteria for Including Substances and Methods on the Prohibited List.
As provided in Article 4.4.3 of the Code, WADA's determination of the Prohibited Substances and Prohibited Methods that will be included on the Prohibited List shall be final and shall not be subject to challenge by an Athlete or other Person.
7.4 Therapeutic Use.
Athletes with a documented medical condition requiring the Use of a Prohibited Substance or a Prohibited Method must first obtain a Therapeutic Use Exemption (TUE) in accordance with the WADA International TUE Standard.
7.4.1 Athletes included by ITTF in its Registered Testing Pool and other Athletes prior to their participation in any International Event must obtain a TUE from ITTF (regardless of whether the Athlete previously has received a TUE at the national level). TUEs granted by ITTF shall be reported to TTA and to WADA. Other Athletes subject to Testing must obtain a TUE from a Recognised Medical Authority. TTA shall promptly report any such TUEs to ITTF and WADA, and other relevant Anti-Doping Organisations including ASDA. TUEs which are consistent with the Code and are within that Signatories authority, shall be recognised and respected by all other Signatories.
7.4.2 International-Level Athletes who are included in the ITTF’s Registered Testing Pool, should apply to ITTF for the TUE at the same time the Athlete first provides whereabouts information to the ITTF and, except in emergency situations, no later than 21 days before the Athlete's participation at an International Event.
7.4.3 Athletes participating in International Events who are not included in the ITTF Registered Testing Pool must, except in emergency situations, request a TUE from ITTF no later than 21 days before the Athlete's participation at an International Event.
7.4.4 WADA, at the request of an Athlete or on its own initiation, may
review the granting
or denial of any TUE to an International
Level Athlete or a national level Athlete that is included in a Registered Testing Pool. If WADA determines that the granting
or denial of a TUE did not comply with the
International Standard for Therapeutic
Use Exemptions in force at the time then WADA may reverse that decision.
Decisions on TUE's
are subject to further appeal as provided in Article 16.
8.1 Authority to Test.
All Athletes subject to Doping Control agree to submit to In-Competition Testing and Out-of-Competition Testing (at any time or place, with or without advance notice) by an Anti-Doping Organisation.
8.2 Testing Standards.
All Testing shall be conducted in conformity with the WADA International Standard for Testing in force at the time of Testing.
8.3 Athlete Whereabouts Requirements.
must provide accurate whereabouts
information to the relevant authority
and keep this information updated
at all times.
for providing whereabouts information rests with each Athlete, however, it shall be the responsibility
of TTA to use its best
efforts to assist the relevant Anti-Doping Organisation, including
8.3.1 International level athletes – ITTF shall establish a Registered Testing Pool of those Athletes who are required to provide up-to-date whereabouts information to ITTF. ITTF may revise its Registered Testing Pool from time to time in accordance with its criteria.
Each Athlete in the ITTF Registered Testing Pool shall provide whereabouts information in accordance with the applicable requirements as determined by the ITTF.
An Athlete who fails to satisfy the ITTF applicable requirements will have committed an Anti-Doping Rule Violation pursuant to Article 5.4 of this Anti-Doping Policy.
8.3.2 National level athletes –
shall establish a national
level Registered Testing Pool of Athletes who are
ASDA to establish Registered
Testing Pool .
define and document criteria for Athletes to be included in
Registered Testing Pool in accordance with the
International Testing Standard
188.8.131.52 The criteria shall be reviewed at least annually and updated as required.
184.108.40.206 Athletes included in the Registered Testing Pool may be revised from time to time.
220.127.116.11 Each Athlete in the Registered Testing Pool shall provide whereabouts information in accordance with the applicable requirements as determined by the ASDA
18.104.22.168 An Athlete who fails to satisfy
ASDA applicable requirements
will have committed an Anti-Doping Rule Violation
pursuant to Article 2.4 of the Code and Article 5.4 of this Anti-Doping
8.3.3 Whereabouts information provided pursuant to Articles 8.3.1 and 8.3.2 shall be shared with Anti-Doping Organisations having jurisdiction to test an Athlete on the strict condition that it be used only for Doping Control purposes.
8.4 Retirement and Return to Competition.
An Athlete who has been identified by the ITTF for inclusion in the ITTF’s Registered Testing Pool shall be subject to ITTF retirement and return to Competition requirements.
An Athlete who is included in Registered Testing Pool shall be subject to the following requirements:
8.4.1 An Athlete who wants to retire from Competition must do so by notifying TTA in writing.
8.4.2 An Athlete's retirement date will be the date TTA receives the notice.
8.4.3 Retirement does not:
a. excuse the Athlete from giving a Sample requested on or before their retirement date;
b. prevent the analysis of a Sample given by the Athlete on or before their retirement date;
c. affect the results of Testing under (a) or (b) above; or
d. exempt the Athlete from this Policy in relation to an Anti-Doing Rule Violation committed before their retirement date.
A retired Athlete may make a written
for reinstatement as a member six months after their retirement
date in accordance with Article 8.4.2. The request
is taken to be made on the date TTA receives the request for reinstatement.
8.4.5 Reinstatement will be at the discretion of TTA.
8.4.6 If reinstatement is granted then this Policy will apply to the Athlete from the date of their reinstatement request.
8.4.7 During the 6 month period following the reinstatement request the Athlete must be available for unannounced Out-of-Competition Testing in accordance with this Anti-Doping Policy.
8.4.8 A retired Athlete may not compete in Competitions and Events conducted by or under the auspices of TTA until the following periods expire:
For international Competitions and Events
6 months from the date TTA receives the reinstatement request.
For domestic Competitions and Events
6 months from the date TTA receives the reinstatement request.
8.4.9 An Athlete may apply to the Court of Arbitration for Sport (CAS) Appeals Division to be eligible to compete in international Competitions and Events before the period set out in clause 8.4.8 expires.
8.4.10 An Athlete may apply to the Anti-Doping Control Officer (ADCO) to be eligible to compete in domestic Competitions and Events before the period set out in clause 8.4.8 expires. The ADCO may grant the application if:
(a) the Athlete has been available for Out of Competition Testing;
(b) the results of the Out of Competition Testing have disclosed no violation of this Anti-Doping Policy; and
(c) there is no other evidence
available to the ADCO to suggest that the Athlete has breached
this Anti-Doping Policy during the period of the
h lete’s retirement.
8.5 Selection of Athletes for Testing
8.5.1 At International Events, the ITTF shall determine the number of finishing placement tests, random tests and target tests to be performed.
8.5.2 At National Events,
Doping Control Samples collected under this Anti-Doping Policy shall be analysed in accordance with the following principles:
9.1 Use of Approved Laboratories.
Doping Control Samples collected under this Anti-Doping Policy must be analysed by WADA-accredited laboratories or as otherwise approved by WADA.
9.2 Substances Subject to Detection.
Laboratories shall analyse Doping Control Samples and report results in accordance with the relevant WADA International Standard/s.
10.1 TTA will recognise the results of laboratory analysis of Testing by Anti-Doping Organisations including ASDA conducted in accordance with the WADA International Standard for Testing.
10.2 When the ADCO receives information that a Person may have committed an Anti-Doping Rule Violation, the ADCO will investigate the matter. The ADCO may consult affected/interested parties about their participation in any investigation and/or hearing.
10.3 Results management conducted by TTA shall be consistent with the general principles for effective and fair results management. Results of all Doping Controls shall be reported to ITTF within 14 days of the conclusion of TTA results management process. Any apparent Anti-Doping Rule Violation by an Athlete who is a Member of TTA or who is otherwise subject to this Anti-Doping Policy shall be promptly referred to an appropriate hearing panel established pursuant to Article 11 or national law. Apparent Anti-Doping Rule Violations by Athletes who are Members of another National Sporting Organisation shall be referred to the Athlete’s National Sporting Organisation for hearing.
10.4 Notification of an Alleged Anti-Doping Rule Violation
TTA will not disclose or use information about a person who is alleged to have, or has committed an Anti-Doping Rule Violation except (for a purpose under this policy) to:
a. a sporting organisation of which the person is a member
b. the ASC
c. the AOC, the ACGA, the APC, or
d. another person until after:
i. the Committee, Panel or CAS has made a determination, or
ii. the ADCO has decided not to refer the matter to a hearing.
10.5 For any apparent Anti-Doping Rule Violation TTA will conduct any necessary follow-up investigation and shall then promptly, within 10 days, send the Person a letter ('infraction notice') via registered mail with a confirmation receipt which:
a. notifies the Person of the anti-doping rule/s which appear/s to have been violated and the basis of the violation;
b. encloses a copy of this Policy,
states that the ADCO will refer
the matter to hearing within 14 days (unless
the Person gives a written waiver under clause 10.
states that if the Person does not
respond within 14 days a hearing can be held in absentia or
apply a sanction in accordance with Article 13.
10.6 The ADCO will:
a. immediately disclose information about a Person who is alleged to have or has committed an Anti-Doping Rule Violation under this policy to the ASC, the ITTF, the AOC;
consult the ASC, the ITTF,
c. assist in any investigation and hearing on behalf of the ASC, the ITTF, the AOC; and
d. consult the ASC, the ITTF, the AOC about a joint referral to a hearing.
10.7 The ADCO will refer the matter to a hearing in accordance with Article 11.
10.8 The ADCO may decide not to refer the matter to hearing if the Person in writing:
a. acknowledges they have admitted the Anti-Doping Rule Violation; and
b. waives the right to hearing in relation to:
i. whether the Person committed an Anti-Doping Rule Violation; and
ii. what sanction apply.
TTA will then apply sanction as set out in Article 13.
10.9 Provisional Suspensions.
may impose a Provisional Suspension
on any Person whose Sample is the subject of an Adverse
Analytical Finding or who is issued with an infraction notice or who
is subject to an investigation.
10.9.2 TTA may impose the following Provisional Suspension:
a. suspend financial or other assistance to the Person;
b. suspend the Person from Competition in Events and Competitions conducted by or under the auspices of TTA; and
c. suspend the Person's licence or participation permit (if relevant).
10.9.3 TTA may apply the Provisional Suspension
e date of the infraction notice;
ollowing the 14 day submission
deemed appropriate by the TTA,
until the determination of the hearing.
10.9.4 An Athlete must be given an opportunity for a Provisional Hearing before imposition of the Provisional Suspension. The hearing can be held in absentia.
10.9.5 If a Provisional Suspension is imposed, the hearing in accordance with Article 11 shall be advanced to a date which avoids substantial prejudice to the Athlete.
11.1 Principles of a Fair Hearing
All hearings conducted pursuant to Article 11 will respect the following principles:
· a timely hearing;
· fair and impartial hearing body;
· the right to be represented by counsel at the Person's own expense;
· the right to be fairly and timely informed of the asserted Anti-Doping Rule Violation;
· the right to respond to the asserted Anti-Doping Rule Violation and resulting consequences;
· the right of each party to present evidence, including the right to call and question witnesses (subject to the hearing body's discretion to accept testimony by telephone or written submission);
· the Person's right to an interpreter at the hearing, with the Doping Panel to determine the identity, and responsibility for the cost of the interpreter; and
· a timely, written, reasoned decision.
Subject to these principles, the hearing will be conducted in the manner that the hearing body determines is appropriate, with as little formality and technicality, and as quickly, as proper consideration of the issue permits.
11.2 The ADCO will wait 14 days (or a shorter period agreed
between the ADCO and the Person) after sending a letter under
then will appoint to conduct the hearing:
a. a committee established in accordance with the rules of the ITTF;
The Chair of the hearing committee/panel must hold current legal qualifications.
11.3 The ITTF Committee/Panel or the CAS will determine:
a. if the Person has committed a violation of this Anti-Doping Policy;
b. if so, what sanction will apply; and
c. how long the sanction will apply.
11.4 The Committee/Panel or the CAS will give the ADCO a written statement of:
a. the findings of the hearing;
b. what sanction (if any) will apply; and
c. for how long the sanction (if any) will apply.
be in accordance with Article 13.
11.5 Results of all Anti-Doping Rule Violations shall be reported to the ASC, ASDA, ITTF AOC and other relevant organisations within 14 days of the conclusion of the results management process.
11.6 Hearings pursuant to this Article shall be completed expeditiously and in all cases, unless there are exceptional circumstances, within three months of the date of the infraction notice described in Article 10.5. Hearings held in connection with Events may be conducted by an expedited process.
11.7 The ASC, ASDA, the AOC and the ITTF shall have the right to attend hearings as an observer or interested party.
11.8 Decisions by TTA, whether as the result of a hearing or the Athlete or other Person's acceptance of consequences, may be appealed as provided in Article 16.
11.9 Hearing decisions by TTA shall not be subject to further administrative review at the national level except as provided in Article 16 or required by applicable national law.
A violation of this Anti-Doping Policy in connection with an In-Competition test automatically leads to Disqualification of the individual result obtained in that Competition with all resulting consequences, including forfeiture of any medals, points and prizes.
13.1 Disqualification of Results in Event During which an Anti-Doping Rule Violation Occurs.
An Anti-Doping Rule Violation occurring during or in connection with an Event may lead to Disqualification of all of the Athlete's individual results obtained in that Event with all consequences, including forfeiture of all medals, points and prizes, except as provided in Article 13.1.1.
13.1.1 If the Athlete establishes that he or she bears No Fault or Negligence for the violation, the Athlete's individual results in the other Competition shall not be disqualified unless the Athlete's results in Competition other than the Competition in which the Anti-Doping Rule Violation occurred were likely to have been affected by the Athlete's Anti-Doping Rule Violation.
13.2 Imposition of Ineligibility for Prohibited Substances and Prohibited Methods. Except for the specified substances identified in Article 13.3, the period of Ineligibility imposed for a violation of Article 5.1 (presence of Prohibited Substance or its Metabolites or Markers), Article 5.2 (Use or Attempted Use of Prohibited Substance or Prohibited Method) and Article 5.6 (Possession of Prohibited Substances and Methods) shall be:
First violation: Two (2) years' Ineligibility.
Second violation: Lifetime Ineligibility.
However, the Athlete or other Person shall have the opportunity in each case, before a period of Ineligibility is imposed, to establish the basis for eliminating or reducing this sanction as provided in Article 13.6.
13.3 Specified Substances.
The Prohibited List may identify specified substances which are particularly susceptible to unintentional Anti-Doping Rules Violations because of their general availability in medicinal products or which are less likely to be successfully abused as Doping agents. Where an Athlete can establish that the Use of such a specified substance was not intended to enhance sport performance, the period of Ineligibility found in Article 13.2 shall be replaced with the following:
a minimum, a warning and reprimand and no period of Ineligibility
from future Events, and
at a maximum, one (1) year's Ineligibility.
Second violation: Two (2) years' Ineligibility.
Third violation: Lifetime Ineligibility.
However, the Athlete or other Person shall have the opportunity in each case, before a period of Ineligibility is imposed, to establish the basis for eliminating or reducing (in the case of a second or third violation) this sanction as provided in Article 13.6.
13.4 Additional Sanction
the ASC, the AOC, the APC, the ACGA
occurrence of the Anti-Doping Rule Violation.
A Committee or the CAS may determine that a Person
who has committed an Anti-Doping Rule Violation,
, is required
to go to counselling for a specified period.
13.4.3 Where the hearings or appeals body determines that an employee or contractor of TTA has committed an Anti-Doping Rule Violation, TTA will take disciplinary action against the employee or contractor.
13.5 Ineligibility for Other Anti-Doping Rule Violations.
The period of Ineligibility for other violations of this Anti-Doping Policy shall be:
13.5.1 For violations of Article 5.3 (refusing or failing to submit to Sample collection) or Article 5.5 (Tampering with Doping Control), the Ineligibility periods set forth in Article 13.2 shall apply.
13.5.2 For violations of Article 5.7 (Trafficking) or Article 5.8 (administration of Prohibited Substance or Prohibited Method), the period of Ineligibility imposed shall be a minimum of four (4) years up to lifetime Ineligibility. An Anti-Doping Rule Violation involving a Minor shall be considered a particularly serious violation, and, if committed by Athlete Support Personnel for violations other than specified substances referenced in Article 13.3, shall result in lifetime Ineligibility for such Athlete Support Personnel. In addition, violations of such Articles which also violate non-sporting laws and regulations, may be reported to the competent administrative, professional or judicial authorities.
13.5.3 For violations of Article 5.4 (Whereabouts Violations or Missed Tests), the period of Ineligibility shall be:
First violation: Three (3) months to one (1) year Ineligibility.
Second and subsequent violations: Two (2) years' Ineligibility.
13.6 Elimination or Reduction of Period of Ineligibility Based on Exceptional Circumstances.
If the Athlete establishes in an individual case involving
Rule Violation under Article 5.1 (presence of Prohibited Substance or its Metabolites
or Markers) or Use of a Prohibited Substance or
Prohibited Method under Article
5.2 that he or she bears No Fault or Negligence for the violation,
the otherwise applicable period of
Ineligibility shall be eliminated. When a Prohibited Substance
or its Markers or Metabolites is detected in an Athlete's
Specimen in violation of Article
5.1 (presence of Prohibited Substance), the Athlete must also establish
how the Prohibited Substance entered his or her system in order
to have the period of Ineligibility eliminated. In the Event
this Article is applied and the period of Ineligibility otherwise
applicable is eliminated, the Anti-Doping Rule Violation shall not
be considered a violation for the limited
purpose of determining the period of Ineligibility for
under Article 13.2, 13.3 and 13.5.
13.6.2 This Article 13.6.2 applies only to Anti-Doping Rule Violations involving Article 5.1 (presence of Prohibited Substance or its Metabolites or Markers), Use of a Prohibited Substance or Prohibited Method under Article 5.2, failing to submit to Sample collection under Article 5.3, or administration of a Prohibited Substance or Prohibited Method under Article 5.8. If an Athlete establishes in an individual case involving such violations that he or she bears No Significant Fault or Negligence, then the period of Ineligibility may be reduced, but the reduced period of Ineligibility may not be less than one-half of the minimum period of Ineligibility otherwise applicable. If the otherwise applicable period of Ineligibility is a lifetime, the reduced period under this section may be no less than 8 years. When a Prohibited Substance or its Markers or Metabolites is detected in an Athlete's Specimen in violation of Article 5.1 (presence of Prohibited Substance), the Athlete must also establish how the Prohibited Substance entered his or her system in order to have the period of Ineligibility reduced.
13.6.3 The ITTF may also reduce the period of Ineligibility in an individual case where the Athlete has provided substantial assistance to the ITTF which results in the ITTF discovering or establishing an Anti-Doping Rule Violation by another Person involving Possession under Article 5.6.2 (Possession by Athlete Support Personnel), Article 5.7 (Trafficking), or Article 5.8 (administration to an Athlete). The reduced period of Ineligibility may not, however, be less than one-half of the minimum period of Ineligibility otherwise applicable. If the otherwise applicable period of Ineligibility is a lifetime, the reduced period under this Article may be no less than 8 years.
13.7 Rules for Certain Potential Multiple Violations
13.7.1 For purposes of imposing sanctions under Article 13.2, 13.3, 13.4 and 13.5, a second Anti-Doping Rule Violation may be considered for purposes of imposing sanctions only if the ITTF or TTA can establish that the Athlete or other Person committed the second Anti-Doping Rule Violation after the Athlete or other Person received notice, or after the ITTF or TTA made a reasonable attempt to give notice, of the first Anti-Doping Rule Violation; if the ITTF or TTA cannot establish this, the violations shall be considered as one single first violation, and the sanction imposed shall be based on the violation that carries the more severe sanction.
13.7.2 Where an Athlete, based on the same Doping Control, is found to have committed an Anti-Doping Rule Violation involving both a specified substance under Article 13.3 and another Prohibited Substance or Prohibited Method, the Athlete shall be considered to have committed a single Anti-Doping Rule Violation, but the sanction imposed shall be based on the Prohibited Substance or Prohibited Method that carries the most severe sanction.
13.7.3 Where an Athlete is found to have committed two separate Anti-Doping Rule Violations, one involving a specified substance governed by the sanctions set forth in Article 13.3 (specified substances) and the other involving a Prohibited Substance or Prohibited Method governed by the sanctions set forth in Article 13.2 or a violation governed by the sanctions in Article 13.5.1, the period of Ineligibility imposed for the second offence shall be at a minimum two years' Ineligibility and at a maximum three years' Ineligibility. Any Athlete found to have committed a third Anti-Doping Rule Violation involving any combination of specified substances under Article 13.3 and any other Anti-Doping Rule Violation under Article 13.2 or 13.5.1 shall receive a sanction of lifetime Ineligibility.
13.8 Disqualification of Results in Competitions Subsequent to Sample Collection.
In addition to the automatic Disqualification of the results in the Competition which produced the positive Sample under Article 12 (Automatic Disqualification of Individual Results), all other competitive results obtained from the date a positive Sample was collected (whether In-Competition or Out-of-Competition), or other Doping violation occurred, through the commencement of any Provisional Suspension or Ineligibility period, shall, unless fairness requires otherwise, be Disqualified with all of the resulting consequences including forfeiture of any medals, points and prizes.
13.9 Commencement of Ineligibility Period.
The period of Ineligibility shall start on the date of the hearing decision providing for Ineligibility or, if the hearing is waived, on the date Ineligibility is accepted or otherwise imposed. Any period of Provisional Suspension (whether imposed or voluntarily accepted) shall be credited against the total period of Ineligibility to be served. Where required by fairness, such as delays in the hearing process or other aspects of Doping Control not attributable to the Athlete, TTA imposing the sanction may start the period of Ineligibility at an earlier date commencing as early as the date of Sample collection.
13.10 Status During Ineligibility.
No Person who has been declared Ineligible may, during the period of Ineligibility, participate in any capacity in an Event or activity (other than authorised anti-doping education or rehabilitation programs) authorised or organised by ITTF or TTA or its Members. This would preclude, but not be limited to:
a. practising/training with a national team;
b. acting as a coach or sport official;
c. selection in any representative team;
d. competing in any Competition/Events;
e. receiving, directly or indirectly, funding or assistance from TTA;
f. use of official TTA or Member facilities;
g. holding any position with TTA.
In addition, for any Anti-Doping Rule Violation not involving specified substances described in Article 13.3, some or all sport-related financial support or other sport-related benefits received by such Person will be withheld by the ITTF or TTA. A Person subject to a period of Ineligibility longer than four years may, after completing four years of the period of Ineligibility, participate in local sport Events in a sport other than sports subject to the jurisdictions of the ITTF or TTA, but only so long as the local sport Event is not at a level that could otherwise qualify such Person directly or indirectly to compete in (or accumulate points toward) a national championship or International Event.
This article would not prohibit the Person from participating in sport on a purely recreational level.
13.11 Reinstatement Testing.
a condition to
regaining eligibility at the end of a specified period of Ineligibility, an Athlete must, during any period of Provisional Suspension or Ineligibility, make him or herself available
for Out-of-Competition Testing by the ITTF or TTA, and any other Anti-Doping Organisation having Testing jurisdiction, and must provide current and accurate whereabouts information as
provided in Article 8.3. If
an Athlete subject to a period of Ineligibility retires from sport and is removed from
Testing ols and later seeks reinstatement, the Athlete shall not be eligible for reinstatement
until the Athlete has notified the ITTF or TTA and has been subject to Out-of-Competition
Testing for a period of time equal to the longer
of the period set forth in Article 8.4 or the period of Ineligibility
remaining as of the date the Athlete
14.1 If a Member of a doubles team or team is found to have committed a violation of this Anti-Doping Policy during an Event, the doubles team or team shall be Disqualified from the Event.
15.1 A Person may make an application to the ADCO for review of a finding of an Anti-Doping Rule Violation or a sanction where new and relevant information becomes available which was:
a. not considered by the Committee/Panel or the CAS at the hearing; and
b. not available to the Person at the time of the hearing.
15.2 The application must:
a. be in writing; and
b. set out the new and relevant information.
15.3 The ADCO will consider the application and if
consider it more than not that the new information would have altered either
the finding of an Anti-Doping Rule Violation or the sanction will refer the application to the Committee/Panel or the
a. review the finding that the Person committed the Doping offence; and
b. decide whether to reduce or withdraw the sanction.
15.4 Any review conducted pursuant to Article 15.3 will apply Articles
4, 5, 6, 7, 12 and 13 of
15.5 A sanction will remain in force during the review unless the Committee or the CAS decides otherwise.
15.6 The ADCO must inform:
a. the Person;
b. any relevant sporting organisations;
c. the ASC;
e. the AOC, the APC, or the ACGA; and
f. any Person or organisation informed of the original determination under clause 11.6,
change to the original determination as a result of the review. The ADCO may then inform other Persons or
organisations as the ADCO
16.1 Decisions Subject to Appeal.
made under this Anti-Doping Policy may be appealed as set forth below in Article
16.2 through 16.4. Such decisions shall remain in effect while
under appeal unless the appellate body orders otherwise. Before an appeal is commenced,
any post-decision review authorised in Article
11. must be exhausted.
16.2 Appeals from Decisions Regarding Anti-Doping Rule Violations, Consequences, and Provisional Suspensions.
decision that an Anti-Doping Rule Violation was committed, a decision
an Anti-Doping Rule Violation, a decision that no Anti-Doping
Rule Violation was committed, a decision that the ITTF
or TTA lacks
jurisdiction to rule on an alleged Anti-Doping Rule Violation
or its consequences,
and a decision to impose a Provisional Suspension as a result of a Provisional Hearing or otherwise in violation of Article 10. may
be appealed exclusively as provided in this Article 16.2. Notwithstanding
any other provision herein, the only Person that may appeal from a Provisional Suspension is the Athlete or other Person upon whom the Provisional Suspension is imposed.
16.2.1 In cases
arising from Competition in an International Event or in cases involving International-Level
Athletes, the decision may be
appealed exclusively to CAS in accordance with the provisions
applicable before such court. Any such appeal will
apply Articles 4, 5, 6, 7, 12 and 13 of
cases involving Athletes that do not have a right to appeal
under Article 16.2.1,
respect the following principles of natural
justice: a timely hearing, a fair and
impartial hearing body; the right to be represented by a counsel at the Person's
expense; and a timely, written,
reasoned decision. Any such appeal will apply Articles 4, 5, 6, 7,
12 and 13 of Anti-Doping
22.214.171.124 Any appeal from a determination of the
must be solely
and exclusively resolved by the CAS Appeals Division. The determination of the CAS Appeals Division will
be final and binding on the parties to the appeal and no Person may
institute or maintain proceedings in any court or tribunal other than the
CAS Appeals Division. In particular, and without restricting the generality
of the foregoing and for further and better assurance, notwithstanding that
such provisions have no applicability, neither party will have the right
of appeal under Section 3 of the Commercial Arbitration Act of any of the
Australian States or to apply for the determination of a question of law
under Section 39(1)(a) of such Act.
126.96.36.199 The ADCO must inform any Person or organisation informed of the original determination of any change to the original determination as a result of the appeal.
188.8.131.52The outcome of all appeals must be reported to the ASC and ASDA the AOC and the ITTF
184.108.40.206 The ADCO may then inform other Persons
or organisations as the ADCO thinks appropriate
rights of appeal with respect
to these cases a set forth in Article 16.2.3.
16.2.3 In cases under Article 16.2.1, the following parties shall have the right to appeal to CAS:
(a) the Athlete or other Person who is the subject of the decision being appealed;
(b) the other party to the case in which the decision was rendered;
(c) ITTF and any other Anti-Doping Organisation under whose rules a sanction could have been imposed;
(d) the International Olympic Committee or International Paralympic Committee, as applicable, where the decision may have an effect in relation to the Olympic Games or Paralympic Games, including decisions affecting eligibility for the Olympic Games or Paralympic Games; and
In cases under Article 16.2.2, the parties having the right to appeal to the national-level
, at a minimum, shall include:
(a) the Athlete or other Person who is the subject of the decision being appealed;
(b) the other party to the case in which the decision was rendered;
(c) ITTF; and
An appeal will be a re-hearing of the matters appealed against and the provisions of Clause 11 will apply, mutatis mutandis to any appeal.
For cases under Article 16.2.2, the ASC, WADA, the ITTF the AOC, and the APC shall also have the right to appeal to CAS with respect to the decision of the national-level reviewing body.
16.3 Appeals from Decisions Granting or Denying a Therapeutic Use Exemption.
Decisions by WADA reversing the grant or denial of a TUE may be appealed exclusively to CAS by the Athlete, ITTF or TTA or other body designated by TTA which granted or denied the exemption. Decisions to deny TUEs, and which are not reversed by WADA, may be appealed by International-Level Athletes to CAS and by other Athletes to the national level reviewing body described in Article 16.2.2. If the national level reviewing body reverses the decision to deny a TUE, that decision may be appealed to CAS by WADA.
16.4 Time for Filing Appeals.
time to file an appeal to CAS shall be within twenty (20) days of the
17.1 Incorporation of Relevant Anti-Doping Rules.
TTA shall comply with the ITTF Anti-Doping
Any procedural rules necessary
to effectively implement this Anti-Doping Policy shall be deemed to be included
in . The Rules of each Member Organisation shall specifically
provide that all Athletes, Athlete Support Personnel and
other Persons under the
jurisdiction of the Member Organisation shall be bound by this Anti-Doping Policy.
17.2 Public Disclosure.
17.2.1 TTA must not publicly disclose the identity of a Person who is suspected of an Anti-Doping Rule Violation until it has been determined in a hearing in accordance with Article 11 that an Anti-Doping Rule Violation has occurred, or such hearing has been waived, or the assertion of an Anti-Doping Rule Violation has not been timely challenged, and no appeal has been lodged against any determination made.
17.2.2 No later than twenty (20) days after an
Anti-Doping matter has been finally determined,
must Publicly Report
its result including any sanction imposed.
17.3 Recognition of Decisions by IF and other National Sporting Organisations.
decision of an
Anti-Doping Organisation regarding a violation
Anti-Doping shall be recognised by all
National Sporting Organisations, which shall take all necessary action to render such results
Subject to the right to appeal provided in Article 16, the Testing, TUEs and hearing results or other final adjudications of any organisation recognised by the ASC, ITTF AOC, APC, WADA or Signatory to the Code which are consistent with the Code and are within the ASC, IF, AOC, APC, WADA or Signatory's authority, shall be recognised and respected by TTA. TTA may recognise the same actions of other bodies which have not accepted the Code if the rules of those bodies are otherwise consistent with the Code and or the ASC’s position.
No action may be commenced under this Anti-Doping Policy against an Athlete or other Person for a violation of an Anti-Doping Rule contained in this Anti-Doping Policy unless such action is commenced within eight years from the date the violation occurred.
Intentionally eft ank
21.1 This Anti-Doping Policy may be amended from time to
subject to ASC approval.
21.2 Except as provided in Article 21.5,
be interpreted as
an independent and autonomous text and not by reference to existing law or statutes.
21.3 The headings used for the various Parts and Articles of this Anti-Doping Policy are for convenience only and shall not be deemed part of the substance of this Anti-Doping Policy or to affect in any way the language of the provisions to which they refer.
21.4 The INTRODUCTION and the APPENDIX I DEFINITIONS shall be considered integral parts of this Anti-Doping Policy.
21.5 This Anti-Doping Policy
been adopted pursuant to the
applicable provisions of the Code and shall be interpreted in a manner that
is consistent with applicable
provisions of the Code. The comments annotating various provisions of the Code may, where applicable, assist in the understanding
and interpretation of this Anti-Doping Policy.
This Anti-Doping Policy shall not apply retrospectively to matters
the date this Anti-Doping
Policy came into effect.
Words in the singular include
the plural and vice versa.
A Person includes a
Words not defined in this policy have the
meaning ascribed to them in the Code unless a contrary meaning appears
from the context.
Reference to “including” and
similar words are not words of limitation.
Adverse Analytical Finding. A report from a laboratory or other approved Testing entity that identifies in a Specimen the presence of a Prohibited Substance or its Metabolites or Markers (including elevated quantities of endogenous substances) or evidence of the Use of a Prohibited Method.
Anti-Doping Control Officer
(ADCO). Means the
Anti-Doping Control Officer appointed by the
to give effect to this Policy and, if no Person is appointed the Chief
Executive or equivalent officer of
Anti-Doping Organisation. A Signatory that is responsible for adopting rules for initiating, implementing or enforcing any part of the Doping Control process. This includes, for example, the International Olympic Committee, the International Paralympic Committee, other Major Event Organisations that conduct Testing at their Events, WADA, International Federations, and National Anti-Doping Organisations.
Anti-Doping Rule Violation. As outlined in Article 5.
(a) For purposes of Doping Control, any Person who participates in sport at the
international level (as defined by each International Federation)
or national level (as defined by each National Anti-Doping Organisation)
and any additional Person who participates in sport at a lower level
if designated by the Person's National Anti-Doping Organisation.
For purposes of anti-doping
information and education, any
Person who participates
in sport under the authority of any Signatory, government, or other sports organisation
accepting the Code;
(b) any Person who:
(i) is registered with
one of its Members; or
participates, or has in the previous five years participated, in any
sporting activity conducted, authorised, recognised or controlled, either
directly or indirectly, by
a body affiliated with ; or
(iii) has otherwise agreed to be bound by this Anti-Doping Policy.
Athlete Support Personnel. Any coach, trainer, manager, agent, team staff, official, parent of a minor or guardian, medical or para-medical working with or treating Athletes participating in or preparing for sports Competition.
Attempt. Purposely engaging in conduct that constitutes a substantial step in a course of conduct planned to culminate in the commission of an Anti-Doping Rule Violation. Provided, however, there shall be no Anti-Doping Rule Violation based solely on an Attempt to commit a violation if the Person enunciates the Attempt prior to it being discovered by a third party not involved in the Attempt.
Australian Olympic Committee (AOC). Means the Australian Olympic Committee Inc.
Australian Paralympic Committee (APC). Means the Australian Paralympic Committee Inc.
Australian Sports Commission (ASC). Means the Australian Sports Commission established by the Australian Sports Commission Act 1989.
Australian Sports Drug Agency (ASDA). Means the Australian Sports Drug Agency established by the Australian Sports Drug Agency Act 1990.
Australian Sports Drug Medical Advisory Committee (ASDMAC). Means the Australian Sports Drug Medical Advisory Committee established by the Australian Sports Drug Agency Act 1990.
Code. The World Anti-Doping Code.
Competition. A single race, match, game or singular athletic contest. For example, the finals of the Olympic 100-meter dash. For stage races and other athletic contests where prizes are awarded on a daily or other interim basis the distinction between a Competition and an Event will be as provided in the rules of the applicable International Federation.
Consequences of Anti-Doping
Violations. An Athlete's or other Person's violation
of an anti-doping rule may result in one or more of the following:
(a) Disqualification means the Athlete's results in a particular Competition or Event are invalidated, with all resulting consequences including forfeiture of any medals, points and prizes;
(b) Ineligibility means the Athlete or other Person is barred for a specified period of time from participating
in any Competition or other activity or funding as
provided in Article
[and (c) Provisional Suspension means the Athlete or other Person is barred temporarily from participating in any Competition prior to the final decision at a hearing conducted under Article 11 (Right to a Fair Hearing).]
Court of Arbitration for Sport
the Court of Arbitration of Sport (
Disqualification. See Consequences of Anti-Doping
Doping. The occurrence of one or more of the Anti-Doping Rule Violations set forth in Article 5.1 through Article 5.8 of this Anti-Doping Policy.
Doping Control. The process including test distribution planning, Sample collection and handling, laboratory analysis, results management, hearings and appeals.
Endogenous. Refers to a substance which is capable of being produced by the body naturally.
Event. A series of individual Competitions conducted together under one ruling body (e.g., the Olympic Games, FINA World Championships, or Pan American Games).
Exogenous. Refers to a substance which is not capable of being produced by the body naturally.
In-Competition. For purposes of differentiating between In-Competition and Out-of-Competition Testing, unless provided otherwise in the rules of an International Federation or other relevant Anti-Doping Organisation, an In-Competition test is a test where an Athlete is selected for Testing in connection with a specific Competition.
Independent Observer Program. A team of observers, under the supervision of WADA, who observe the Doping Control process at certain Events and report on observations. If WADA is Testing In-Competition at an Event, the observers shall be supervised by an independent organisation.
Ineligibility. See Consequences of Anti-Doping Rule
International Event. An Event where the International Olympic Committee, the International Paralympic Committee, an International Federation, a Major Event Organisation, or another international sport organisation is the ruling body for the Event or appoints the technical officials for the Event.
International-Level Athlete. Athletes designated by one or more International Federations as being within the Registered Testing Pool for an International Federation.
International Standard. A standard adopted by WADA in support of the Code. Compliance with an International Standard (as opposed to another alternative standard, practice or procedure) shall be sufficient to conclude that the procedures addressed by the International Standard were performed properly.
ITTF. MeansInternational Table Tennis Federation
Major Event Organisations. This term refers to the continental associations of National Olympic Committees and other international multi-sport organisations that function as the ruling body for any continental, regional or other International Event.
Marker. A compound, group of compounds or biological parameters that indicates the Use of a Prohibited Substance or Prohibited Method.
Member. A Person who, or a body
which, is a Member of
; a Person
who, or body which, is affiliated with
Metabolite. Any substance produced by a biotransformation process.
Mimetic. A substance with pharmacological effect similar to that of
another substance, regardless of the fact that it has a different chemical
Minor. A natural Person who has not reached the age of majority as established by the applicable laws of his or her country of residence.
National Anti-Doping Organisation. The entity(ies) designated by each country as possessing
the primary authority and responsibility to adopt and implement anti-doping rules, direct the collection of Samples,
the management of test results, and
the conduct of hearings, all
at the national level. If this designation has not been made by the competent public authority(ies), the entity shall be the country's National Olympic Committee or its designee.
National Event. A sport Event involving international or national-level Athletes that is not an International Event.
National Olympic Committee. The organisation recognised by the International Olympic Committee. The term National Olympic Committee shall also include the National Sport Confederation in those countries where the National Sport Confederation assumes typical National Olympic Committee responsibilities in the anti-doping area.
National Sporting Organisation. A national or regional
entity which is a Member of or is recognised by
as the entity governing th sport in that nation or region or is recognised
by the ASC as a National Sporting Organisation. This includes National Sporting Organisations for Athletes
with a Disability.
No Advance Notice. A Doping Control which takes place with no advance warning to the Athlete and where the Athlete is continuously chaperoned from the moment of notification through Sample provision.
No Fault or Negligence. The Athlete's establishing that he or she did not know or suspect, and could not reasonably have known or suspected even with the exercise of utmost caution, that he or she had Used or been administered the Prohibited Substance or Prohibited Method.
No Significant Fault or Negligence. The Athlete's establishing that his or her fault or negligence, when viewed in the totality of the circumstances and taking into account the criteria for No Fault or Negligence, was not significant in relationship to the Anti-Doping Rule Violation.
Out-of-Competition. Any Doping Control which is not In-Competition.
Participant. Any Athlete or Athlete Support Personnel.
Person. A natural Person or an organisation or other entity, including an Athlete, Athlete Support Personnel and Member.
Possession. The actual, physical
the constructive (which
shall be found only if the Person
has exclusive control over the Prohibited Substance/Method
or the premises in which a Prohibited
Substance/Method exists); provided, however, that if the Person
does not have exclusive control over the Prohibited Substance/Method or the premises in which a Prohibited Substance/Method exists, constructive shall only be found if the Person knew about the presence of the Prohibited Substance/Method
and intended to exercise control over it. Provided,
however, there shall be no Anti-Doping
Rule Violation based solely on Possession if, prior
to receiving notification of any kind that the Person has committed an Anti-Doping Rule Violation, the Person has taken concrete
action demonstrating that the Person
no longer intends to have Possession and has renounced the Person's previous
Prohibited List. The List identifying the Prohibited Substances and Prohibited Methods.
Prohibited Method. Any method so described on the Prohibited List.
Prohibited Substance. Any substance so described on the Prohibited List.
Provisional Hearing. For purposes of Article 10.5, an expedited abbreviated hearing occurring prior to a hearing under Article 11 (Right to a Fair Hearing) that provides the Athlete with notice and an opportunity to be heard in either written or oral form.
[Provisional Suspension. See Consequences above.]
Publicly Disclose or Publicly Report. To disseminate or distribute information to the general public or Persons beyond those Persons entitled to earlier notification in accordance with Article 17.
Recognised Medical Authority. The Australian Sports Drug Medical Advisory Committee (ASDMAC), or an authority recognised by the ASDMAC which may authorise the Use of a Prohibited Substance and/or Prohibited Method for a therapeutic purpose.
Registered Testing Pool. The pool of top level Athletes established separately by each International Federation and National Anti-Doping Organisation who are subject to both In-Competition and Out-of-Competition Testing as part of that International Federation's or Organisation's test distribution plan.
Sample/Specimen. Any biological material collected for the purposes of Doping Control.
Signatories. Those entities signing the Code and agreeing to comply with the Code, including the International Olympic Committee, International Federations, International Paralympic Committee, National Olympic Committees, National Paralympic Committees, Major Event Organisations, National Anti-Doping Organisations, and WADA.
Sporting Organisation. Means the Australian Olympic Committee, Australian Commonwealth Games Association, Australian Paralympic Committee and any organisation recognised, assisted or funded by the ASC and includes their Member and affiliated organisations.
Tamperinq. Altering for an improper purpose or in an improper way; bringing improper influence to bear; interfering improperly to alter results or prevent normal procedures from occurring.
Target Testing. Selection of Athletes for Testing where specific Athletes or groups of Athletes are selected on a non-random basis for Testing at a specified time.
Team Sport. A sport in which the substitution of players is permitted during a Competition.
Testing. The parts of the Doping Control process involving test distribution planning, Sample collection, Sample handling, and Sample transport to the laboratory.
Therapeutic Use Exemption (TUE). Means Therapeutic Use Exemption in accordance with the WADA International Standard for Therapeutic Use Exemptions.
Trafficking. To sell, give, administer, transport, send, deliver or distribute a Prohibited Substance or Prohibited Method to an Athlete either directly or through one or more third parties, but excluding the sale or distribution (by medical Personnel or by Persons other than an Athlete's Support Personnel) of a Prohibited Substance for genuine and legal therapeutic purposes.
Use. The application, ingestion, injection or consumption by any means whatsoever of any Prohibited Substance or Prohibited Method.
WADA. The World Anti-Doping Agency.
 In March 2004, the 2004 WADA was accessible on the internet through the web site of the World Anti-Doping Agency (www.wada-ama.org).
 In March 2004, the International Standard for Laboratory Analysis was accessible on the internet through the web site of the World Anti-Doping Agency (www.wada-ama.org).
 In March 2004, the International Standard for Testing was accessible on the internet through the web site of the World Anti-Doping Agency (www.wada-ama.org).
 In March 2004, the 2004 WADA Prohibited List was accessible on the internet through the web site of the World Anti-Doping Agency (www.wada-ama.org).